Related references
Note: Only part of the references are listed.Different Facets of Copy Number Changes: Permanent, Transient, and Adaptive
Sweta Mishra et al.
MOLECULAR AND CELLULAR BIOLOGY (2016)
Too little O2 Too much gain
Joshua C. Black et al.
CELL CYCLE (2015)
Hypoxia drives transient site-specific copy gain and drug-resistant gene expression
Joshua C. Black et al.
GENES & DEVELOPMENT (2015)
The Clinical Relevance of the miR-197/CKS1B/STAT3-mediated PD-L1 Network in Chemoresistant Non-small-cell Lung Cancer
Yu Fujita et al.
MOLECULAR THERAPY (2015)
miR-23b-3p regulates the chemoresistance of gastric cancer cells by targeting ATG12 and HMGB2
Y. An et al.
CELL DEATH & DISEASE (2015)
A Coding Single-Nucleotide Polymorphism in Lysine Demethylase KDM4A Associates with Increased Sensitivity to mTOR Inhibitors
Capucine Van Rechem et al.
CANCER DISCOVERY (2015)
Tumor suppressive microRNA-137 negatively regulates Musashi-1 and colorectal cancer progression
Amber R. Smith et al.
ONCOTARGET (2015)
Predicting effective microRNA target sites in mammalian mRNAs
Vikram Agarwal et al.
ELIFE (2015)
MicroRNAs in Cancer
Gianpiero Di Leva et al.
ANNUAL REVIEW OF PATHOLOGY: MECHANISMS OF DISEASE, VOL 9 (2014)
MicroRNA-137 down-regulates KIT and inhibits small cell lung cancer cell proliferation
Peipei Li et al.
BIOMEDICINE & PHARMACOTHERAPY (2014)
Regulation of microRNA biogenesis
Minju Ha et al.
NATURE REVIEWS MOLECULAR CELL BIOLOGY (2014)
miR-137 suppresses cell growth in ovarian cancer by targeting AEG-1
Jinling Guo et al.
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2013)
KDM4A Lysine Demethylase Induces Site-Specific Copy Gain and Rereplication of Regions Amplified in Tumors
Joshua C. Black et al.
CELL (2013)
miR-137 inhibits the proliferation of lung cancer cells by targeting Cdc42 and Cdk6
Xiaolan Zhu et al.
FEBS LETTERS (2013)
c-MYC-regulated miR-23a/24-2/27a Cluster Promotes Mammary Carcinoma Cell Invasion and Hepatic Metastasis by Targeting Sprouty2
Xiaoni Li et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2013)
Targeted genomic sequencing of pediatric Burkitt lymphoma identifies recurrent alterations in antiapoptotic and chromatin-remodeling genes
Lisa Giulino-Roth et al.
BLOOD (2012)
Shortening of 3′UTRs Correlates with Poor Prognosis in Breast and Lung Cancer
Antonio Lembo et al.
PLOS ONE (2012)
Inhibition of PTEN Gene Expression by Oncogenic miR-23b-3p in Renal Cancer
Mohd Saif Zaman et al.
PLOS ONE (2012)
Hallmarks of Cancer: The Next Generation
Douglas Hanahan et al.
CELL (2011)
The SKP1-Cul1-F-box and Leucine-rich Repeat Protein 4 (SCF-FbxL4) Ubiquitin Ligase Regulates Lysine Demethylase 4A (KDM4A)/Jumonji Domain-containing 2A (JMJD2A) Protein
Capucine Van Rechem et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2011)
SCFFBXO22 Regulates Histone H3 Lysine 9 and 36 Methylation Levels by Targeting Histone Demethylase KDM4A for Ubiquitin-Mediated Proteasomal Degradation
Meng-Kwang Marcus Tan et al.
MOLECULAR AND CELLULAR BIOLOGY (2011)
Weak seed-pairing stability and high target-site abundance decrease the proficiency of lsy-6 and other microRNAs
David M. Garcia et al.
NATURE STRUCTURAL & MOLECULAR BIOLOGY (2011)
MicroRNAs en route to the clinic: progress in validating and targeting microRNAs for cancer therapy
Andrea L. Kasinski et al.
NATURE REVIEWS CANCER (2011)
Conserved Antagonism between JMJD2A/KDM4A and HP1γ during Cell Cycle Progression
Joshua C. Black et al.
MOLECULAR CELL (2010)
The landscape of somatic copy-number alteration across human cancers
Rameen Beroukhim et al.
NATURE (2010)
Over-expression of CKS1B activates both MEK/ERK and JAK/STAT3 signaling pathways and promotes myeloma cell drug-resistance
Lei Shi et al.
ONCOTARGET (2010)
Role of Cks1 amplification and overexpression in breast cancer
Xiao-Chun Wang et al.
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2009)
Mcl1 downregulation sensitizes neuroblastoma to cytotoxic chemotherapy and small molecule Bcl2-family antagonists
Brian J. Lestini et al.
CANCER BIOLOGY & THERAPY (2009)
Widespread Shortening of 3′UTRs by Alternative Cleavage and Polyadenylation Activates Oncogenes in Cancer Cells
Christine Mayr et al.
CELL (2009)
Copy number variation at 1q21.1 associated with neuroblastoma
Sharon J. Diskin et al.
NATURE (2009)
c-Myc suppression of miR-23a/b enhances mitochondrial glutaminase expression and glutamine metabolism
Ping Gao et al.
NATURE (2009)
Comprehensive genomic characterization defines human glioblastoma genes and core pathways
L. Chin et al.
NATURE (2008)
Assessing the significance of chromosomal aberrations in cancer: Methodology and application to glioma
Rameen Beroukhim et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2007)
Characterizing the cancer genome in lung adenocarcinoma
Barbara A. Weir et al.
NATURE (2007)
Prognostic value of chromosome 1q21 gain by fluorescent in situ hybridization and increase CKS1B expression in myeloma
R. Fonseca et al.
LEUKEMIA (2006)
Conserved seed pairing, often flanked by adenosines, indicates that thousands of human genes are microRNA targets
BP Lewis et al.
CELL (2005)
Amplification and overexpression of CKS1B at chromosome band 1q21 is associated with reduced levels of p27(Kip1) and an aggressive clinical course in multiple myeloma
J Shaughnessy
HEMATOLOGY (2005)
Overexpression of PDZK1 within the 1q12-q22 amplicon is likely to be associated with drug resistance phenotype in multiple myeloma
J Inoue et al.
AMERICAN JOURNAL OF PATHOLOGY (2004)
Chromosomal imbalances of primary and metastatic lung adenocarcinomas
A Goeze et al.
JOURNAL OF PATHOLOGY (2002)
Share Paper
